Senior Director, Global Product Lead, Early Oncology R&D

AstraZeneca
Cambridge, United Kingdom
2 days ago
Job Type
Permanent
Work Pattern
Full-time
Work Location
On-site
Seniority
Director
Education
Phd
Posted
5 May 2026 (2 days ago)

Benefits

Excellent benefits

Title: Senior Director, Global Product Lead, Early Oncology R&D

Location: Cambridge, UK

Salary: Competitive, with excellent benefits

As Senior Director and Global Product Lead, this role holds end-to-end leadership for multiple early global product teams spanning IO, ADC and Cell Therapy platforms, from candidate selection through Phase III investment decision. Acting as the “CEO” of each asset, this position shapes and drives the strategy, execution and differentiation of a portfolio of oncology candidates. The remit includes critically assessing science, clinical data and the competitive landscape, then translating insights into clear development strategies that align with the broader oncology vision. This position engages diverse stakeholders, communicates complex plans with clarity, and steers teams through key decision points that influence the future of cancer treatment.

Ready to lead assets that could redefine standards of care?

Accountabilities

  • End-to-end product leadership: Lead global product teams from preclinical candidate selection through proof of concept and Phase III investment decisions, with potential extension into late-stage development and registration.

  • Single point of accountability: Own strategy, budget, timelines, and execution across a portfolio of preclinical and clinical-stage oncology assets.

  • Differentiated development plans: Develop and own integrated product strategies that align with business objectives and clearly differentiate assets versus competitors.

  • Governance excellence: Present and defend strategies at governance forums to secure funding, endorsement, and alignment on critical milestones.

  • Data-driven agility: Continuously monitor scientific and clinical signals, anticipate inflection points, and pivot program strategies to maximize value and patient impact.

  • Proactive risk management: Identify, mitigate, and communicate risks across global teams to enable transparent, timely decision-making.

  • Influence without authority: Foster a high-performing, collaborative environment by coaching cross-functional colleagues and strengthening team cohesion.

  • External engagement: Build trusted relationships with investigators and partners to ensure programs reflect evolving practice patterns, unmet needs, and real-world patient perspectives.

  • Scientific rigor and ethics: Champion patient-centric thinking, data integrity, and ethical standards in every aspect of development.

Essential Qualifications, Skills & Experience

  • Advanced degree: PhD or MD/PhD required.

  • Proven drug development success: Clear record of moving assets through key development stages.

  • Industry experience: Early-phase non-clinical and/or clinical development experience with regulatory awareness.

  • Oncology depth: Strong knowledge of the oncology therapeutic area with experience acrossdiverse biological modalities (e.g., small molecules, biologics, ADCs, cell/gene therapies).

  • Clinical landscape fluency: Broad understanding of evolving standards of care, trial design trends, and competitive dynamics.

  • Leadership in matrixed settings: Demonstrated ability to lead, motivate, and align cross-functional teams.

  • Collaboration track record: Proven success cultivating and managing internal and external partnerships.

  • Influence and communication: Demonstrated ability to influence peers and senior leaders across functions.

  • Integrity: Uncompromising commitment to ethical conduct and patient-first decision-making.

Desirable Skills/Experience

  • Experience in thedevelopment of small molecules is highly desirable.

  • Due diligence experienceas GPLs are often required to participate in companywide initiatives.

AstraZeneca offers an environment where scientific ambition is matched by real-world impact, uniting experts from academia and industry to push the boundaries of oncology research. Work alongside diverse leaders and collaborators across the globe, leveraging extensive external partnerships and cutting-edge platforms to accelerate progress against some of the hardest-to-treat cancers, while building a meaningful long-term career shaped by curiosity, courage and collaboration.

If this opportunity to lead transformative oncology assets resonates, apply now to shape the next generation of cancer therapies!

Date Posted

05-May-2026

Closing Date

18-May-2026Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Related Jobs

View all jobs
Spotlight

Senior Director Global Clinical Program Lead Cardiovascular & Renal

CSL
On-site

Medical Director, Senior Patient Safety Physician

AstraZeneca Chatham, ME4 4NP, United Kingdom
Hybrid

VP, Global Medical Lead - Vaccines

GSK United Kingdom
£150,000 – £250,000 pa On-site

VP, Global Medical Lead - Vaccines

GSK
£150,000 – £250,000 pa On-site

VP, Global Medical Lead - Vaccines

GSK
£150,000 – £250,000 pa On-site

Director – Process Design and Optimisation in Chemical Development

AstraZeneca Macclesfield, United Kingdom
£100,000 – £150,000 pa Hybrid

Director External Manufacturing Procurement

GSK
£80,000 – £120,000 pa On-site

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Where to Advertise Biotech Jobs in the UK (2026 Guide)

Advertising biotech jobs in the UK requires a different approach to most technical hiring. The candidate pool spans life scientists, computational biologists, regulatory specialists and biomanufacturing engineers — each with distinct professional networks and job search behaviours. General job boards reach a broad audience but lack the specificity that biotech professionals expect. Specialist platforms, academic channels and sector-specific communities each serve a different part of the market. This guide, published by BiotechnologyJobs.co.uk, covers where to advertise biotech roles in the UK in 2026, how the main platforms compare, what employers should expect to pay, and what the data says about hiring across different role types.

Biotech Jobs UK 2026: What to Expect Over the Next 3 Years

Biotechnology is creating jobs at a rate that few other sectors can match. New disciplines are emerging from research labs and entering commercial hiring pipelines, existing roles are fragmenting into deeper specialisms, and the technologies driving it all — from AI-assisted drug discovery to next-generation gene editing — are advancing faster than the workforce can keep pace with. For job seekers, this creates an unusual challenge. In most industries, career planning means navigating a relatively familiar landscape and identifying where your skills fit. In biotech, that landscape is being actively redrawn. The roles generating the most hiring activity in 2028 may look quite different from the ones appearing in job adverts today. That's not a reason to feel overwhelmed — it's a reason to get informed. The candidates who thrive in this market aren't always those with the longest CVs or the most letters after their name. They're the ones who understand where the sector is heading: which disciplines are gaining commercial traction, which technologies are driving employer demand, and how the definition of a "biotech job" is expanding well beyond traditional pharmaceuticals and research roles. This article breaks down what the UK biotech jobs market is likely to look like over the next three years — covering emerging job titles, the technologies reshaping hiring, the skills employers are prioritising right now, and how to position your career ahead of the curve rather than behind it.

New Biotech Employers to Watch in 2026: UK and Global Companies Transforming Life Sciences Careers

The biotechnology job market in the UK is entering a new phase—one defined by scientific breakthroughs, targeted investment, and a growing pipeline of innovative employers. For professionals browsing BiotechnologyJobs.co.uk, the key question is no longer just which companies exist, but which ones are scaling, hiring, and shaping the future of life sciences. In this article, we explore the new biotech employers to watch in 2026, focusing on UK-based startups, scale-ups, and international firms with a growing UK presence. These organisations have recently secured funding, partnerships, or strategic backing—strong indicators of hiring momentum in the months ahead.